Pharmaceuticals have brought immense health benefits to developing countries, but one third of the world’s population does not have access to existing essential drugs. The Commission on Health Research for Development (1990) showed that less than 10 per cent of global health research is directed towards diseases that afflict 90% of the world’s population. IPRs in pharmaceuticals have two principal areas of impact which affect public health. First, there is the issue of access, where discussion focuses on the links between IPRs, exclusion of competitors and the availability and pricing of new medicines. Second, there is the issue of incentive innovation, where discussion focuses on the role of IPRs in motivating R&D and marketing of new drugs and the effect of IPRs on R&D expenditure and its allocation across diseases, countries and organizations.
"synopsis" may belong to another edition of this title.
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Pharmaceuticals have brought immense health benefits to developing countries, but one third of the world's population does not have access to existing essential drugs. The Commission on Health Research for Development (1990) showed that less than 10 per cent of global health research is directed towards diseases that afflict 90% of the world's population. IPRs in pharmaceuticals have two principal areas of impact which affect public health. First, there is the issue of access, where discussion focuses on the links between IPRs, exclusion of competitors and the availability and pricing of new medicines. Second, there is the issue of incentive innovation, where discussion focuses on the role of IPRs in motivating R&D and marketing of new drugs and the effect of IPRs on R&D expenditure and its allocation across diseases, countries and organizations. 64 pp. Englisch. Seller Inventory # 9786139851003
Quantity: 2 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. Seller Inventory # 26390073021
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand. Seller Inventory # 389526882
Quantity: 4 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND. Seller Inventory # 18390073015
Quantity: 4 available
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Goyal AnjuDr Anju Goyal is Professor in Pharmaceutical Chemistry and Head of Department of Pharmaceutical Quality Assurance at BN Institute of Pharmaceutical Sciences, Udaipur. Dr Kamal Singh Rathore is Head of Department at Pharmace. Seller Inventory # 385874291
Quantity: Over 20 available
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Pharmaceuticals have brought immense health benefits to developing countries, but one third of the world's population does not have access to existing essential drugs. The Commission on Health Research for Development (1990) showed that less than 10 per cent of global health research is directed towards diseases that afflict 90% of the world's population. IPRs in pharmaceuticals have two principal areas of impact which affect public health. First, there is the issue of access, where discussion focuses on the links between IPRs, exclusion of competitors and the availability and pricing of new medicines. Second, there is the issue of incentive innovation, where discussion focuses on the role of IPRs in motivating R&D and marketing of new drugs and the effect of IPRs on R&D expenditure and its allocation across diseases, countries and organizations.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 64 pp. Englisch. Seller Inventory # 9786139851003
Quantity: 1 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Pharmaceuticals have brought immense health benefits to developing countries, but one third of the world's population does not have access to existing essential drugs. The Commission on Health Research for Development (1990) showed that less than 10 per cent of global health research is directed towards diseases that afflict 90% of the world's population. IPRs in pharmaceuticals have two principal areas of impact which affect public health. First, there is the issue of access, where discussion focuses on the links between IPRs, exclusion of competitors and the availability and pricing of new medicines. Second, there is the issue of incentive innovation, where discussion focuses on the role of IPRs in motivating R&D and marketing of new drugs and the effect of IPRs on R&D expenditure and its allocation across diseases, countries and organizations. Seller Inventory # 9786139851003
Quantity: 1 available
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Intellectual Property Rights: Abstract Book | Anju Goyal (u. a.) | Taschenbuch | 64 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9786139851003 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Seller Inventory # 114111812
Quantity: 5 available
Seller: Mispah books, Redhill, SURRE, United Kingdom
paperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book. Seller Inventory # ERICA82961398510096
Quantity: 1 available